Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Increase in Short Interest

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 394,700 shares, a growth of 94.1% from the November 30th total of 203,400 shares. Based on an average trading volume of 2,390,000 shares, the short-interest ratio is currently 0.2 days.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on AEMD. HC Wainwright reissued a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a research note on Friday, November 15th. StockNews.com began coverage on Aethlon Medical in a research note on Thursday. They set a “sell” rating for the company.

Aethlon Medical Stock Performance

AEMD stock traded up $0.02 on Friday, reaching $0.61. The company’s stock had a trading volume of 3,053,982 shares, compared to its average volume of 2,232,336. The business has a fifty day simple moving average of $0.41 and a two-hundred day simple moving average of $0.43. Aethlon Medical has a 12-month low of $0.24 and a 12-month high of $2.35. The firm has a market cap of $8.46 million, a PE ratio of -0.21 and a beta of 1.79.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.